An audit of the use of hydroxychloroquine in rheumatology clinics

An audit of the use of hydroxychloroquine in rheumatology clinics

<strong>Objectives</strong> To audit the use, indications, complications and patient information regarding hydroxychloroquine (HCQ) treatment in rheumatology clinics in a tertiary referral centre. <strong>Methods</strong> During a 9-month period, we identified all patients p...

書誌詳細
主要な著者:	Worth, C, Yusuf, IH, Turner, B, Gourier, H, Brooks, EE, Mort, DO, Sharma, S, Downes, SM, Luqmani, RA
フォーマット:	Journal article
出版事項:	Oxford University Press 2018

類似資料

097 Are we using too much hydroxychloroquine in patients with rheumatic diseases?
著者:: Worth, C, 等
出版事項: (2016)

Hydroxychloroquine retinopathy: an emerging problem.
著者:: Latasiewicz, M, 等
出版事項: (2017)

The incidence, monitoring coverage and clinical characteristics of hydroxychloroquine retinopathy in the United Kingdom
著者:: Yusuf, IH, 等
出版事項: (2024)

Hydroxychloroquine retinopathy.
著者:: Yusuf, I, 等
出版事項: (2017)

An audit of an emergency rheumatology clinic have we improved our service?
著者:: Wong, E, 等
出版事項: (2008)

Hydroxychloroquine hitting the headlines: Retinal considerations
著者:: Downes, SM, 等
出版事項: (2020)

Hydroxychloroquine in Rheumatological Disorders: The Potential Buffer against Coronavirus Disease-19?
著者:: Bhandari, Sudhir, 等
出版事項: (2021-02-01)

Incidence of and risk factors for chloroquine and hydroxychloroquine retinopathy in Thai rheumatologic patients
著者:: Tangtavorn N, 等
出版事項: (2016-11-01)

A nationwide survey of hydroxychloroquine retinopathy presenting to the hospital eye service in the United Kingdom
著者:: Yusuf, IY, 等
出版事項: (2022)

Textbook of orthopaedics, trauma and rheumatology /
著者:: Luqmani, Raashid
出版事項: (2008)

2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis
著者:: Suppiah, R, 等
出版事項: (2022)

Clinical features of acute generalized exanthematous pustulosis caused by hydroxychloroquine in rheumatology patients and exploration of CARD14 gene mutations
著者:: Feng Luo, 等
出版事項: (2023-04-01)

An audit of a combined rheumatology and orthopaedic foot and ankle surgery clinic
著者:: Harris Nick, 等
出版事項: (2010-12-01)

Revisiting cardiac safety of hydroxychloroquine in rheumatological diseases during COVID-19 era: Facts and myths
著者:: Shivraj Padiyar, 等
出版事項: (2021-04-01)

Monitoring for retinal toxicity in patients taking hydroxychloroquine and chloroquine
著者:: Yusuf, IH, 等
出版事項: (2018)

An audit of influenza and pneumococcal vaccination in rheumatology outpatients
著者:: Mitchell William S, 等
出版事項: (2007-07-01)

The Royal College of Ophthalmologists recommendations on monitoring for hydroxychloroquine and chloroquine users in the United Kingdom (2020 revision): executive summary
著者:: Yusuf, IH, 等
出版事項: (2021)

New recommendations for retinal monitoring in hydroxychloroquine users: Baseline testing is no longer supported
著者:: Yusuf, IH, 等
出版事項: (2021)

Joint recommendations for retinal screening in long‐term users of hydroxychloroquine and chloroquine in the United Kingdom, 2018
著者:: Yusuf, IH, 等
出版事項: (2018)

Evaluation Incidence of Ocular Complications of Hydroxychloroquine and Related Risk Factors in Patients with Connective Tissue Disease Referred to the Rheumatology Clinic of Tohid Hospital in Sanandaj
著者:: Nasrin Moghimi, 等
出版事項: (2023-03-01)

Clinical rheumatology
著者:: Anand N Malaviya
出版事項: (2021-01-01)

Hydroxychloroquine-induced Retinal Toxicity
著者:: Imran H. Yusuf, 等
出版事項: (2023-05-01)

Comment on: British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of rheumatoid arthritis (after the first 2 years): reply
著者:: Luqmani, R, 等
出版事項: (2009)

2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis
著者:: Ponte, C, 等
出版事項: (2022)

Rheumatology Clinics “Spondyloarthritis”
著者:: Vineeta Shobha
出版事項: (2021-01-01)

Novel imaging techniques for hydroxychloroquine retinopathy
著者:: Imran H. Yusuf, 等
出版事項: (2022-10-01)

Auto-antibody testing for children on biologic therapies for rheumatological conditions: results of audit
著者:: McCann Liza J, 等
出版事項: (2011-09-01)

The significance of correct dosing of hydroxychloroquine in clinical trials of COVID-19
著者:: Balakrishnan Sadasivam, 等
出版事項: (2020-11-01)

2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis
著者:: Ponte, C, 等
出版事項: (2022)

The Royal College of Ophthalmologists recommendations on screening for hydroxychloroquine and chloroquine users in the United Kingdom: executive summary
著者:: Yusuf, IH, 等
出版事項: (2018)

Unmet needs and future perspectives in hydroxychloroquine retinopathy
著者:: Imran H. Yusuf, 等
出版事項: (2023-06-01)

Novel imaging techniques for hydroxychloroquine retinopathy
著者:: Yusuf, I, 等
出版事項: (2022)

Pain assessment in clinical Rheumatology
著者:: L. Sinigaglia, 等
出版事項: (2001-06-01)

Requirement for retinal screening in patients taking hydroxychloroquine and chloroquine
著者:: Lotery, A, 等
出版事項: (2018)

Brazilian society of rheumatology methodological guide for the development of evidence-based clinical guidelines in rheumatology
著者:: Ana Karla Guedes de Melo, 等
出版事項: (2023-03-01)

Rheumatology and rheumatology research, a mismatch.
著者:: Dixon, A
出版事項: (1992)

The effect of an electronic medical record intervention on hydroxychloroquine prescribing habits and surveyed providers’ opinions of the 2016 American Academy of Ophthalmology guidelines in the rheumatology and dermatology practices of an academic institutionle
著者:: Rebecca S. Overbury, 等
出版事項: (2021-09-01)

British Society for Rheumatology and british health professionals in Rheumatology guideline for the management of rheumatoid arthritis (the first two years).
著者:: Luqmani, R, 等
出版事項: (2006)

Rheumatology practice and training in India – A perspective from rheumatology consultants
著者:: Durga Prasanna Misra, 等
出版事項: (2020-01-01)

Pediatric rheumatology: a clinical viewpoint
著者:: Geetha Rajan, 等
出版事項: (2017-01-01)